Brak połączenia z internetem — wyświetlanie zapisanej wersji strony.

Q32 Bio Inc

USUSD
← Do Screenera
US:QTTBLSE:0T6G

Q32 Bio Inc (US:QTTB) — Biotechnology: Pharmaceutical Preparations. Liczba giełd, na których notowane są akcje spółki: 2. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.

O Firmie

Strona
q32bio.com
Relacje Inwestorskie
ir.q32bio.com/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Siedziba
WALTHAM, United States
Prezes
Jodie Pope Morrison
Pracownicy
22
Akcje w Obrocie
29.77 mln na 2026-08-03
Free Float
14.64 mln
Kapitalizacja Rynkowa
248.28 mln USD
Insiderzy
2.1%
Inwestorzy Instytucjonalni
80.73%
Branża (SIC)
Pharmaceutical Preparations
P/E
2.6
FCF
−33.5 mln USD
Dług
0 USD
gotówka netto
Zyski i FCF — za 12 miesięcy do 30.06.2026 roku (najnowszy raport firmy).
Opis

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti–interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb – CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.

reklama

Giełdy i Tickery

GiełdaTickerWalutaCenaTyp
US USA StocksQTTB główneUSD8.06 -7.78%akcje zwykłe
LSE London Stock Exchange0T6G IOBUSD8.83 +0.00%akcje zwykłe

Cena z 3 Miesięcy

dzień wzrostu dzień spadkuNajedź / dotknij dnia — ceny otwarcia, zamknięcia, najwyższa i najniższa

Najwięksi Akcjonariusze

PosiadaczUdziałAkcjeData Raportu
Orbimed Advisors LLC.13.87%4.13 mln2026-06-30
Boxer Capital Management…10.58%3.15 mln2026-06-30
Atlas Venture Life Scien…9.13%2.72 mln2026-06-30
BVF Inc.7.89%2.35 mln2026-06-30
RA Capital Management, L…7.84%2.33 mln2026-06-30
Point72 Asset Management…3.94%1.17 mln2026-06-30
Opaleye Management Inc.3.13%931 0002026-06-30
Logos Global Management…2.69%800 0002026-06-30
Summittx Capital, L.P.2.46%733 7742026-06-30
Vanguard Capital Managem…1.74%518 8032026-06-30
American Century ETF Tru…1.74%518 2522026-08-31
VANGUARD INDEX FUNDS-Van…1.31%389 1152026-06-30
MORRISON JODIE POPE (Chi…≈1.15%343 2592026-08-25
VIOLETTE SHELIA M (Offic…≈0.55%164 0482026-08-25
KALOWSKI LEE (President)≈0.47%138 4712026-08-25
VANGUARD INDEX FUNDS-Van…0.4%119 2692026-06-30
MANKE ISAAC (Director)≈0.18%53 5212026-06-30
Fidelity Concord Street…0.17%51 0152026-07-31
First TRT Exch-Trd Fd.-F…0.15%45 4112026-08-31
CAMPAGNA JASON (Officer)≈0.13%37 5002025-02-24
Bridgeway Funds, Inc.-Ul…0.12%34 6132026-06-30
iShares Trust-iShares Mi…0.1%29 2712026-08-31
American Century ETF Tru…0.08%22 6222026-08-31
Fidelity Concord Street…0.07%19 7922026-07-31
American Century ETF Tru…0.06%17 8582026-08-31
ORBIMED ADVISORS, L.L.C.…——2026-05-28
XU DIYONG (Director and…——2026-05-28